ArticleVirus genes2026
Whole-genome characterization and antigenic analysis of two distinct duck-origin H6 Subtype avian influenza viruses in China.
Article in Virus genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Avian influenza viruses (AIVs) of the H6 subtype demonstrate broad host tropism and represent a persistent concern for both poultry and public health due to their documented potential for cross-species transmission. This study aimed to isolate and characterize two novel H6 subtype AIVs from duck farms in China, focusing on their genetic evolution, molecular characterization, and antigenic properties. Virus isolation was performed from AIV-positive cloacal swabs. Whole genomes were sequenced and phylogenetically analyzed. Bioinformatic tools were employed to identify critical amino acid motifs, glycosylation patterns, and reassortment events. Antigenic cross-reactivity was evaluated through hemagglutination inhibition (HI) assays. Two strains, designated as H6N6 (SHT) and H6N2 (GXG), were successfully isolated. Phylogenetic analysis classified their hemagglutinin (HA) genes into the ST/2853-like and ST/339-like lineages, respectively. The GXG strain was identified as a triple-reassortant virus, with its matrix (M) gene derived from an H9N2 AIV, and contained a unique arginine insertion at residue 169 of the HA. In contrast, the SHT strain possessed a deletion in the neuraminidase (NA) stalk region (residues 58-68). Asymmetric antigenic cross-reactivity was observed: antiserum against GXG partially inhibited SHT, while SHT antiserum showed no inhibition of GXG. Epidemiological data confirmed the dominance of the ST/2853-like lineage in China, with N6 as the predominant NA subtype from 2015 to 2022. In conclusion, the two H6 AIV isolates exhibit distinct genetic and antigenic characteristics, carry mammalian adaptation markers, and highlight a potential cross-species transmission risk. These findings underscore the necessity for continued surveillance and the development of appropriately matched vaccine candidates.
Indexed as
Identifiers
41931194What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.